Mersana Therapeutics, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Pre-Funded Warrants
Mersana Therapeutics, Inc.
Biotechnology
NY
2024
Offer Letter, dated
Mersana Therapeutics, Inc.
Biotechnology
2024
Letter Agreement
Mersana Therapeutics, Inc.
Biotechnology
MA
2023
Offer Letter, dated September 5, 2023, by and between Mersana Therapeutics, Inc. and Martin Huber
Mersana Therapeutics, Inc.
Biotechnology
MA
2023
Amendment No
Mersana Therapeutics, Inc.
Biotechnology
NY
2023
Agreement Regarding LICR Technology, dated July 9, 2015, by and between Ludwig Institute for Cancer Research, Recepta Biopharma S.A. and Mersana Therapeutics, Inc
Mersana Therapeutics, Inc.
Biotechnology
2023
Description of Securities
Mersana Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated June 15, 2021, between the Company and Tushar Misra
Mersana Therapeutics, Inc.
Biotechnology
2022
Offer Letter, dated March 5, 2021, between the Company and Alejandra Carvajal
Mersana Therapeutics, Inc.
Biotechnology
2022
Amended and Restated Offer Letter, by and between Mersana Therapeutics, Inc. and Michael Kaufman, dated March 8, 2017
Mersana Therapeutics, Inc.
Biotechnology
2021
Offer Letter, by and between Mersana Therapeutics, Inc. and Arvin Yang, dated November 5, 2020
Mersana Therapeutics, Inc.
Biotechnology
2021
Offer Letter, by and between Mersana Therapeutics, Inc. and Brian DeSchuytner, dated June 10, 2019
Mersana Therapeutics, Inc.
Biotechnology
2020
Offer Letter, by and between Mersana Therapeutics, Inc. and Dirk Huebner, dated November 5, 2018
Mersana Therapeutics, Inc.
Biotechnology
2020
Offer Letter, by and between Mersana Therapeutics, Inc. and David Spellman, dated December 18, 2017
Mersana Therapeutics, Inc.
Biotechnology
2019
CONFIDENTIAL
Mersana Therapeutics, Inc.
Biotechnology
2017